C. elegans genes have introns which must be removed from the pre-mRNAs by conventional splicing mechanisms. In addition, the pre-mRNAs undergo two kinds of trans-splicing. SL1 is spliced near the 5' ends of pre-mRNAs that begin with an outron, a short AU-rich sequence followed by a 3' splice site. SL1 is also used to process polycistronic pre-mRNAs from the unusual operons,
cyt-1/ced-9 and
mes-6/cks-1, in which no conventional 3' end formation occurs. SL2 is used to process the more usual kind of polycistronic RNAs, in which the 3' end of the upstream gene is 100 to 400 bp from the trans-splice site of the downstream gene. In an effort to learn the rules by which trans-splicing specificity is determined, we are attempting to reproduce trans-splicing specificity in vitro. We have developed a whole cell in vitro splicing extract from C. elegans embryos. Although it splices relatively inefficiently, it faithfully splices out introns and trans-splices exclusively SL1 to two templates that receive exclusively SL1 in vivo:
rol-6 and
cks-1. However, when a template from a gene that receives exclusively SL2 in vivo is tested in vitro, a mixture of SL1 and SL2 is trans-spliced. In order to test the idea that complete SL2 specificity might involve co-transcription of the polycistronic template with splicing, we have begun experiments in which a modified
gpd-2/gpd-3 operon template is placed downstream of a T7 RNA polymerase promoter, and this template is transcribed in the splicing extract. The products of the reaction are then tested for splicing specificity by RT-PCR. To our astonishment and delight, the operon template receives only SL2 on the
gpd-3 trans-splice site in this experiment, just as it does in vivo. When we mutate the poly(A) site of
gpd-2, the
gpd-3 receives a mixture of SL1 and SL2. This mutation produces a similar result in in vivo tests. However, mutation of the poly(Y) tract just downstream of the
gpd-2 3' end that prevents trans-splicing when tested in vivo, had no effect at all in vitro. A control template (
cks-1) that receives only SL1 when added to the splicing extract, also receives only SL1 when transcribed in the splicing extract. Clearly, we have a ways to go, but we are greatly encouraged by the fact that transcription in the splicing extract reproduces SL2 specificity.